Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Immune Dysfunction in Patients with MDS Is Partially Corrected in EPO-Treated Patients: Differences According to WHO Classification

Howard S Oster, MD PhD, Naamit Deshet-Unger, MSc, Drorit Neumann, PhD, Moshe Mittelman, MD, Nir Maaravi, MD, Sara Prutchi-Sagiv, PhD, Golishevski Nataliya, MD

Blood (2016) 128 (22): 3165.

https://doi.org/10.1182/blood.V128.22.3165.3165

Published: 2016

Journal Articles

Recombinant Erythropoietin and Darbepoetin Alpha Exert a Similar Dose-Dependent Osteopenic Effect Which May Advocate for "Start Low, Go Slow" Dosing Strategy in Clinical Practice

Kolomansky Albert, MD, Sahar Hiram-Bab, PhD, Naamit Deshet-Unger, MSc, Nathalie Ben-Califa, PhD, Dafna Gilboa, MSc, Tamar Liron, PhD, Howard S Oster, MD PhD, Moshe Mittelman, MD, Yankel Gabet, DMD, PhD, Drorit Neumann, PhD

Blood (2016) 128 (22): 2445.

https://doi.org/10.1182/blood.V128.22.2445.2445

Published: 2016

Journal Articles

Transdifferentiation of Bone Marrow Pro-B Cells into Bone-Resorbing Osteoclasts- an Unexpected Role for Erythropoietin

Naamit Deshet-Unger, MSc, Sahar Hiram-Bab, PhD, Nathalie Ben-Califa, PhD, Dafna Gilboa, MSc, Tamar Liron, PhD, Kolomansky Albert, MD, Howard S Oster, MD PhD, Moshe Mittelman, MD, Yankel Gabet, DMD, PhD, Drorit Neumann, PhD

Blood (2016) 128 (22): 5043.

https://doi.org/10.1182/blood.V128.22.5043.5043

Published: 2016

Journal Articles

Erythropoietin Potentiates The Immune System Yet Induces Bone Resorption In a Myeloma Mouse Model

Naamit Deshet-Unger, MSc, Sahar Hiram-Bab, PhD, Mor Gross, Yasmin Haim-Ohana, Miriam C. Souroujon, PhD, Howard S. Oster, MD, PhD, Moshe Mittelman, MD, Yankel Gabet, DMD, PhD, Drorit Neumann, PhD

Blood (2013) 122 (21): 1849.

https://doi.org/10.1182/blood.V122.21.1849.1849

Published: 2013

Journal Articles

Erythropoietin Treatment in Multiple Myeloma – Friend or Foe?

Naamit Deshet-Unger, Msc, Sahar Hiram-Bab, PhD, Yasmin Haim Ohana, Mor Gross, Miriam Souroujon, PhD, Moshe Mittelman, MD, Drorit Neumann, PhD

Blood (2012) 120 (21): 5013.

https://doi.org/10.1182/blood.V120.21.5013.5013

Published: 2012

NARROW

Immune Dysfunction in Patients with MDS Is Partially Corrected in EPO-Treated Patients: Differences According to WHO Classification

Recombinant Erythropoietin and Darbepoetin Alpha Exert a Similar Dose-Dependent Osteopenic Effect Which May Advocate for "Start Low, Go Slow" Dosing Strategy in Clinical Practice

Transdifferentiation of Bone Marrow Pro-B Cells into Bone-Resorbing Osteoclasts- an Unexpected Role for Erythropoietin

Erythropoietin Potentiates The Immune System Yet Induces Bone Resorption In a Myeloma Mouse Model

Erythropoietin Treatment in Multiple Myeloma – Friend or Foe?

Email alerts

ASH Publications

American Society of Hematology

Immune Dysfunction in Patients with MDS Is Partially Corrected in EPO-Treated Patients: Differences According to WHO Classification

Recombinant Erythropoietin and Darbepoetin Alpha Exert a Similar Dose-Dependent Osteopenic Effect Which May Advocate for "Start Low, Go Slow" Dosing Strategy in Clinical Practice

Transdifferentiation of Bone Marrow Pro-B Cells into Bone-Resorbing Osteoclasts- an Unexpected Role for Erythropoietin

Erythropoietin Potentiates The Immune System Yet Induces Bone Resorption In a Myeloma Mouse Model

Erythropoietin Treatment in Multiple Myeloma – Friend or Foe?

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only